Clinical Trials Week
Susan Hasty, Publisher
Table of Contents . . . October 20th, 2008
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Osteoporosis - Unigene Initiates Phase I Clinical Study for Oral PTH
Pain Management - Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints in Second Phase IIa Respiratory Depression Study in Germany
QLT Inc. - QLT announces the initiation of a Phase I trial of its synthetic retinoid product
Type 1 Diabetes - Diamyd(R) Study Published in Prestigious New England Journal of Medicine
Cancer Vaccines - Findings from T. Tsuruma and co-authors broaden understanding of cancer vaccines
Chromatography - New chromatography study findings have been reported by W. Hauck and colleagues
Colon Cancer - Research results from C. Oliva and co-authors update knowledge of colon cancer
Gastric Cancer - Researchers at Yokohama City University release new data on gastric cancer
HIV/AIDS - Research conducted at Brigham and Women's Hospital has updated our knowledge about HIV/AIDS
HIV/AIDS - Scientists at University of British Columbia target HIV/AIDS
HIV/AIDS - University of California details research in HIV/AIDS
Life Sciences - Research in the area of life sciences reported from P.J. Lariccia and colleagues
Myeloma - Research from Kocaeli University broadens understanding of myeloma
Pancreatic Cancer - Research from S. Ina and colleagues provide new insights into pancreatic cancer
Vasculitis - Studies from C. Metzler et al add new findings in the area of vasculitis
Breast Cancer Therapy - Data from Vanderbilt University, Vanderbilt-Ingram Comprehensive Cancer Center advance knowledge in breast cancer therapy
Controlled Release - Findings in controlled release reported from University of California
Fusion Proteins - Recent studies by E. Bouman-Thio and co-authors add new data to fusion proteins findings
Mesothelioma Quality of Care - Study findings from K. Ribi et al provide new insights into mesothelioma quality of care
Non-Small Cell Lung Cancer Therapy - Scientists at University libre of Bruxelles detail research in non-small cell lung cancer therapy
Osteoporosis Therapy - Studies from Institute for Myeloma and Bone Cancer Research add new findings in the area of osteoporosis therapy
Prostate Cancer Therapy - Study results from A.J. Armstrong and colleagues in the area of prostate cancer therapy published
Amsterdam Molecular Therapeutics B.V - AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
Asthma - Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
Avexa Limited - Avexa Bolsters Board of Directors and Appoints New Chairman
Breast Cancer - Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
Cancer Vaccines - BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
Candidiasis - CombinatorX Announces Top-Line Results from Phase 2b Study of Synavive (CRx-102) for Knee Osteoarthritis
Crohn Disease - New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
Cyclacel Pharmaceuticals, Inc. - Cyclacel Announces Completion of Enrollment in Phase 2 Trial of Sapacitabine in Elderly AML
Dysplasia - Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
FoldRx Pharmaceuticals, Inc. - FoldRx Announces Rapid Progress with Development Program for Lead Candidate
Gastroenterology - Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
Hypertension - Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
Immunotherapy - Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
Infantile Spasm - Marinus Pharmaceuticals, Inc., Completes Two Phase 2 Milestones for Ganaxolone in Epilepsy
Inspire Pharmaceuticals, Inc. - Inspire Initiates Phase 1 Trial of INS117548 for Glaucoma
Irritable Bowel Syndrome - Salix Presents New Phase II Data Evidence Demonstrating the Clinical Utility of Rifaximin in Irritable Bowel Syndrome (IBS); Results Presented at American College of Gastroenterology Annual Meeting Demonstrate Quality
NewsRx - NewsRx Launches New Business Titles, Offers Free Global Warming Publication
Obesity and Diabetes - Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Poniard Pharmaceuticals, Inc. - Poniard Pharmaceuticals Exercises Option to Draw Down $10 Million Second Tranche of Loan Facility
Salix Pharmaceuticals, Ltd. - Rifaximin Demonstrates Highly Statistically Significant Results in Prevention of Hepatic Encephalopathy in Pivotal Phase 3 Study
Sosei Group Corporation - NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
Surgery - Circassia Acquires North American and Japanese Rights to Dopexamine
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
